Fundação Internacional para a Gestão do Sangue dos Doentes (IFPBM)

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease (Um ensaio de Darbepoetina Alfa na diabetes tipo 2 e doença renal crónica).

Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; os investigadores TREAT. N Engl J Med. 2009 Nov 19;361(21):2019-2032. Epub 2009 Oct 30.

Resumo